The Public Health Research Programme (PHR) is accepting Stage 1 applications to their commissioned workstream for this topic.
In order to apply you will need to carefully review the:
Our calls are being supported by Public Health Research Applications and Design Advice (PHRADA), which is provided by the NIHR Research Design Service (RDS) across England. If you would like to request support for this call, please contact PHRADA by email firstname.lastname@example.org.
Applicants, from England, who have not been funded by the PHR Programme before are required to provide proof that contact has been made with the PHRADA service.
Any changes to these dates will be emailed to all Lead Applicants with an application in progress.
- Stage one deadline: 1pm on 15 August 2023
- Notification of out of remit/non-competitive decision if unsuccessful: Late August 2023
- Notification of stage one shortlisting decision: mid/end October 2023
- Stage two writing window: mid/end October to mid December 2023
- Notification of stage two funding decision: early March 2024
- Earliest start date for funded studies: 1 June/1 July 2024
Please note: If a very high response is received, some applications may not be taken forward for further assessment if they are deemed to be non-competitive and/or it may be necessary to defer some applications until a later date. 'Non-Competitive' means that an application is not of a sufficiently high standard to be taken forward for further assessment in comparison with other applications received and funded by the PHR Programme because it has little or no realistic prospect of funding. This may be because of scientific quality, cost, scale/duration, or the makeup of the project team.
All primary research projects are expected to establish a programme appointed Study/Trial Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.
A webinar took place on Tuesday 21 February 2023, if you would like access to the slides and a recording of the webinar please email email@example.com